Journals / TSK Koruyucu Hekimlik Bülteni / 2012 / Cilt: 11 - Sayı: 2

How should the screening programs be planned for the early diagnosis of breast cancer

Meme kanseri için erken tanı ve tarama programları nasıl olmalıdır?

Pages
225–230
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

By the help of effective screening programmes and organizations related to breast cancer awareness, downstaging of breast cancer and reduction in mortality rate in community could be possible.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Breast cancer is the most common cancer of women, and it ranks as the second leading cause of cancer death in women.
📊
Key Findings & Data:Although breast cancer incidence in western countries is higher than developping countries, very favorable survival rates in the developed countries have been attributed to early detection by screening.
💡
Conclusion & Impact:By the help of effective screening programmes and organizations related to breast cancer awareness, downstaging of breast cancer and reduction in mortality rate in community could be possible.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Breast cancer is the most common cancer of women, and it ranks as the second leading cause of cancer death in women. Although breast cancer incidence in western countries is higher than developping countries, very favorable survival rates in the developed countries have been attributed to early detection by screening. Despite screening mammography have been used for a long time, there is not a strong consensus related to when to start?, how frequently to screen?, and when to finish screening. Many factors including the risk stratification of patient, incidence of breast cancer, social and economic status, the availability of mammography and medical team should be considered when creating national screening programs. Today, the most effective way to reduce breast cancer mortality is early diagnosis and treatment. By the help of effective screening programmes and organizations related to breast cancer awareness, downstaging of breast cancer and reduction in mortality rate in community could be possible.

Özet

Meme kanseri kadınlarda en sık görülen kanserdir ve kadınlarda kansere bağlı ölümlerin ikinci en sık nedenidir. Batı ülkelerinde meme kanseri insidansı gelişmekte olan ülkelere kıyasla daha yüksek olmasına rağmen, kansere bağlı mortalitenin daha düşük olması yaygın ve etkili tarama programlarının uygulanması ile kanserin erken evrede yakalanıp tedavi edilmesine bağlanmaktadır. Mamografi tarama amacıyla uzun zamandır kullanımda olmasına rağmen, taramaya ne zaman başlanması gerektiği, ne sıklıkla uygulanacağı ve ne zaman sonlandırılacağı ile ilgili halen kesin uzlaşılar yoktur. Ülkeler kendi tarama programlarını oluştururken hastanın risk durumu, meme kanseri insidansı, sosyal ve ekonomik faktörler, mamografi ve sağlık ekibinin yeterliliği gibi birçok unsuru gözönünde bulundurmalıdır. Günümüzde meme kanserine bağlı mortaliteyi azaltmanın en etkin yolu erken tanı ve tedavidir. Etkili tarama programları ve meme kanseri farkındalığını arttırıcı organizasyonlar sayesinde meme kanserini erken evrede saptamak ve kansere bağlı mortaliteyi azaltmak mümkündür.

🔖

Cite This Article

KILBAŞ, Z., YILDIZ, R., ÖZTÜRK, E. (2012). How should the screening programs be planned for the early diagnosis of breast cancer. TSK Koruyucu Hekimlik Bülteni, Cilt: 11 - Sayı: 2, 225–230. https://ajindex.com/articles/129094

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011; 61: 212
  2. Özmen V, Fidaner V, Aksaz Ğ, Bayol W, Dede İ, Göker E ve ark. Türkiye’de Meme Kanseri Erken Tanı ve Tarama Programlarının Hazırlanması. Meme Sağlığı Dergisi. 2009; 5(3): 125-134 3. Gail MH, Costantino JP, Pee D, Bondy M, Newman L, Selvan M, et al. Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst. 2007; 99(23): 1782-92
  3. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989; 81(24): 1879- 86. 5. www.seer.cancer.gov/csr/1975_2000/ [Erişim Tarihi: 10.03.2012]
  4. Barton MB, Harris R, Fletcher SW. The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be done? How? JAMA. 1999; 282(13): 1270-80
  5. Bobo JK, Lee NC, Thames SF. Findings from 752,081 clinical breast examinations reported to a national screening program from 1995 through 1998. J Natl Cancer Inst. 2000; 92(12): 971-6
  6. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst. 2000; 92(18): 1490-9
  7. Chiarelli AM, Majpruz V, Brown P, Theriault M, Shumak R, Mai V. The contribution of clinical breast examination to the accuracy of breast screening. J Natl Cancer Inst. 2009; 101(18): 1236-43
  8. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009; 151(10): 727-37
  9. Fenton JJ, Rolnick SJ, Harris EL, Barton MB, Barlow WE, Reisch LM, et al. Specificity of clinical breast examination in community practice. J Gen Intern Med. 2007; 22(3): 332-7
  10. Okonkwo QL, Draisma G, der Kinderen A, Brown ML, de Koning HJ. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India. J Natl Cancer Inst. 2008; 100(18): 1290-300
  11. Kösters JP, Gotzsche PC. Regular self-examination or clinical examination for early detection of breast cancer. Cochrane Database Syst Rev. 2003;(2): CD003373
  12. Thomas DB, Gao DL, Ray RM, Wang WW, Allison CJ, Chen FL. Randomized trial of breast self-exami